We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.18B
AUM Growth
+$413M
Cap. Flow
+$293M
Cap. Flow %
7.01%
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$20M
2
NVDA icon
NVIDIA
NVDA
+$19M
3
JNJ icon
Johnson & Johnson
JNJ
+$14.9M
4
KO icon
Coca-Cola
KO
+$14.6M
5
MSFT icon
Microsoft
MSFT
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 24.63%
2 Consumer Discretionary 12.15%
3 Technology 12.08%
4 Industrials 12%
5 Healthcare 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIL icon
1351
Instil Bio
TIL
$49M
$32.8K ﹤0.01%
+2,975
New +$36.4K
CEI
1352
DELISTED
Camber Energy, Inc
CEI
$31.9K ﹤0.01%
+50,000
New +$59.7K
AUMN
1353
DELISTED
Golden Minerals Company
AUMN
$29.2K ﹤0.01%
18,000
TOVX icon
1354
Theriva Biologics
TOVX
$10.2M
$28.5K ﹤0.01%
1,141
TKAT
1355
DELISTED
Takung Art Co., Ltd.
TKAT
$26.6K ﹤0.01%
76,000
AMTI
1356
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$25.8K ﹤0.01%
100,000
MITQ icon
1357
Moving iMage Technologies
MITQ
$5.36M
$23.8K ﹤0.01%
20,300
LFLY
1358
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$22.9K ﹤0.01%
3,945
-1,250
-24% -$8.49K
PRHI
1359
Presurance Holdings
PRHI
$20.6M
$22.9K ﹤0.01%
1,857
IGC icon
1360
IGC Pharma
IGC
$25.6M
$21.5K ﹤0.01%
69,000
ZYNE
1361
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$21.5K ﹤0.01%
65,900
SNCE
1362
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$21.3K ﹤0.01%
5,000
-2,470
-33% -$14K
GOSS icon
1363
Gossamer Bio
GOSS
$88.7M
$20.4K ﹤0.01%
17,000
-178,900
-91% -$223K
PHGE icon
1364
BiomX
PHGE
$1.97M
$17.8K ﹤0.01%
261
SQZ
1365
DELISTED
SQZ Biotechnologies Company
SQZ
$17.8K ﹤0.01%
65,800
ITP icon
1366
IT Tech Packaging
ITP
$3.04M
$17.6K ﹤0.01%
37,500
JVA icon
1367
Coffee Holding Co
JVA
$19.4M
$15.4K ﹤0.01%
11,100
-11,900
-52% -$19.8K
NEXI
1368
DELISTED
NexImmune, Inc. Common Stock
NEXI
$13.9K ﹤0.01%
2,000
TLPH icon
1369
Talphera
TLPH
$69M
$13.7K ﹤0.01%
12,370
NXU
1370
DELISTED
Nxu, Inc. Class A Common Stock
NXU
$7.96K ﹤0.01%
5
MIND icon
1371
MIND Technology
MIND
$45.7M
$7.88K ﹤0.01%
1,252
-10,700
-90% -$60.1K
FOXO
1372
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$7.75K ﹤0.01%
126
NCMI icon
1373
National CineMedia
NCMI
$392M
$7.41K ﹤0.01%
2,200
-20,000
-90% -$60.2K
AKA icon
1374
a.k.a. Brands
AKA
$124M
$5.16K ﹤0.01%
1,000
CPHI icon
1375
China Pharma Holdings
CPHI
$47.8M
$4.95K ﹤0.01%
290

Similar funds

Bridgeway Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bridgeway Capital Management held 1,500 positions worth $4.18B, up 11% from $3.77B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Bridgeway Capital Management deployed $293M of net new capital in Q2 2023, opening 123 new positions and adding to 567 existing holdings. Its largest new stake was Tronox: 919,025 shares worth $11.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Permian Resources, an estimated $14.3M trimmed.

  • Bridgeway Capital Management's largest Q2 2023 buy was Tronox: 919,025 shares worth $11.7M.
  • Bridgeway Capital Management added most to JPMorgan Chase in Q2 2023, an estimated $20M increase.
  • Bridgeway Capital Management's biggest Q2 2023 reduction was Permian Resources, cutting an estimated $14.3M.
  • Bridgeway Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $21.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.7% of its $4.18B portfolio in Q2 2023.
  • Bridgeway Capital Management opened 123 new positions and closed 123 in Q2 2023.
  • Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.18B.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.